Stocks Health care BCYC
NASDAQ · Health careBicycle Therapeutics PLC (BCYC)
Bicycle Therapeutics PLC brought in $61.2M of revenue over the twelve months to June 30, 2026, up 217.4% from a year earlier. It posted a net loss of $190.4M. In fiscal 2025 capital spending exceeded operating cash flow by $252M. At June 30, 2026 it held $510.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 30, 2026.
What Bicycle Therapeutics PLC does
Bicycle Therapeutics PLC is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker BCYC.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $72.6M | -$219M | -$3.16 | -$252M |
| 2024 | $35.3M | -$169M | -$2.90 | -$166M |
| 2023 | $27M | -$180.7M | -$5.08 | -$63.6M |
| 2022 | $14.5M | -$112.7M | -$3.80 | -$105.1M |
| 2021 | $11.7M | -$66.8M | -$2.67 | -$16.8M |
| 2020 | $10.4M | -$51M | -$2.66 | -$19M |
Latest SEC filings
What Bicycle Therapeutics PLC has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 20, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- July 30, 2026Quarterly report 10-Q · period to June 30, 2026
- July 30, 2026
- June 18, 2026
- May 21, 2026Other event 8-K
- May 15, 2026Passive stake changed SCHEDULE 13G/A
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
- May 4, 2026Passive stake changed SCHEDULE 13G/A
- April 30, 2026Quarterly report 10-Q · period to March 31, 2026
Questions about BCYC
What does Bicycle Therapeutics PLC do?
Bicycle Therapeutics PLC is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker BCYC.
Is Bicycle Therapeutics PLC profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $190.4M on revenue of $61.2M.
How much revenue does Bicycle Therapeutics PLC make?
Over the twelve months to June 30, 2026 Bicycle Therapeutics PLC reported revenue of $61.2M. That is 217.4% more than a year earlier.
When did Bicycle Therapeutics PLC last report?
Its most recent periodic report is the quarterly report (10-Q) filed on July 30, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the executive or director change from August 20, 2026.
Similar companies
Follow BCYC
Get an email when Bicycle Therapeutics PLC files with the SEC: results, executive changes, material agreements and annual reports.
Follow BCYC: get an email when it filesWhere the numbers come from
Financial figures are the values Bicycle Therapeutics PLC tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.